NCT04022876 2022-10-10A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)Aileron Therapeutics, Inc.Phase 1 Terminated35 enrolled
NCT01187615 2014-07-08Determination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung CancerBayerPhase 1 Terminated9 enrolled